Supplementary Figure S2 from Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models
Authors:
- Sonia JainSJSonia Jain
- Jessica I. GriffithJGJessica I. Griffith
- Kendra A. PorathKPKendra A. Porath
- Sneha RathiSRSneha Rathi
- Jiayan LeJLJiayan Le
- Tugce I. PasaTPTugce I. Pasa
- Paul A. DeckerPDPaul A. Decker
- Shiv K. GuptaSGShiv K. Gupta
- Zeng HuZHZeng Hu
- Brett L. CarlsonBCBrett L. Carlson
- Katrina BakkenKBKatrina Bakken
- Danielle M. BurgenskeDBDanielle M. Burgenske
Open Access
- 1 August 2024
- other
- Published by American Association for Cancer Research (AACR)